Anindita De

Rewiring Immune Tolerance: A Case study of Tolerogenic Vaccine Strategies for FOXP3+ Regulatory T Cell Expansion in Type 1 Diabetes

While intercepting Type 1 Diabetes prior to clinical onset remains challenging, early intervention represents a critical therapeutic frontier. In T1D, the immune system fails to maintain central and peripheral tolerance, targeting and selectively destroying pancreatic beta cells....